Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
Irina TsibulakElisabeth ReiserGerhard BognerEdgar PetruJohanna Hell-TeutschAlexander ReinthallerCornelia WeiratherTatjana WeissSzabolcs BozsaBarbara PuschacherMirijam HallDoris HittlerKatharina HraudaElisabeth ThellSabine ClaussJohanna PozniakSebastian AlickeDaniela GanglGottfried GamperlChristoph EbnerKatharina KnollKatharina LeitnerAndrea SchilcherMarina SchinnerlVerena SiglChristian SingerThomas AigmüllerBirgit HofstätterChristian MarthPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
The lockdown led to a decreased number of newly diagnosed gynecological and breast cancers. The decreased accessibility of the medical services and postponed diagnosis of potentially curable cancers during the COVID-19 pandemic may be a step backwards in our healthcare system and might impair cancer treatment outcomes. Therefore, new strategies to manage early cancer detection are needed to optimize cancer care in a time of pandemic in the future.